Substance / Medication

Aluminium hydroxide

Overview

Active Ingredient
aluminum hydroxide
RxNorm CUI
612

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
The effect of a combination antacid preparation containing aluminium hydroxide and magnesium hydroxide on rosuvastatin pharmacokinetics.
Martin Paul D, Schneck Dennis W, Dane Aaron L et al. · Curr Med Res Opin · 2008
PMID: 18355422RCT
The effect of replacing aluminium hydroxide with calcium acetate/magnesium carbonate on serum phosphorus control in haemodialysis patients.
Arroyo David, Panizo Nayara, Abad Soraya et al. · Nefrologia · 2014
PMID: 24658194Observational
The structure of HBsAg particles is not modified upon their adsorption on aluminium hydroxide gel.
Greiner Vanille J, Ronzon Frédéric, Larquet Eric et al. · Vaccine · 2012
PMID: 22705175Observational
Venom immunotherapy: aqueous vs aluminium hydroxide adsorbed extracts.
Müller U R · Allergy · 2004
PMID: 15147441Observational
Ginseng and aluminium hydroxide act synergistically as vaccine adjuvants.
Rivera E, Hu S, Concha C · Vaccine · 2003
PMID: 12559792Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Aluminium hydroxide (substance)
SNOMED CT
273944007
UMLS CUI
C0002371
RxNorm CUI
612

Clinical Data

This intervention maps to 4 entities in the Ltrl knowledge graph.

4
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.